SCOT FLYNN

Child, Adolescent & Adult Psychiatry, Psychopharmacology, Psychiatric Research

Scot provides a diverse set of skills across all age groups, including developmental-behavioral pediatrics, psychopharmacology, and men's issues.

​

His clinical focus extends into addiction psychiatry, providing comprehensive aid for individuals confronting substance use and alcohol use disorders.

​

Since 2008 Scot has a gained wealth of experience facilitating psychiatric research, and has spearheaded innovative strategies for mental illness treatments including advances in Ketamine treatments.

Scot's clinical tenure includes pivotal roles at eminent institutions such as Yale University's Bridgeport Hospital, Providence Memorial Hospital, Cross Creek Hospital, and Austin Recovery Center where he demonstrated proficiency in both inpatient and outpatient settings.  

 ​

Scot has been awarded the CAQ Certificate of Advanced Qualifications in Psychiatry.

​

In addition, Scot's work has extended to global health initiatives, contributing his medical expertise to underserved communities worldwide . These international endeavors have fundamentally shaped his approach to patient care, underscoring his belief in the vital role of comprehensive mental health treatment in enabling individuals to realize their inherent potential.

​​

Scot specializes in:​​

• Male Mental Health Services

• Male Hormone Replacement Therapy

• Advanced Psychopharmacology

• Addiction Medicine

• Outpatient Detox

• Office-Based Ketamine Treatment

• Attention Deficit Disorder ADD

• Attention Deficit Hyperactivity Disorder ADH

• Obsessive Compulsive Disorder OCD

• Post Traumatic Shock Disorder PTSD

• Anxiety Disorders

• Autism

• Depression

• Bipolar Disorder

• Schizophrenia